Abstract: Clustered cell-free networking that dynamically decomposes a network into multiple subnetworks is emerging as a promising solution to the cell-edge problem in mobile communication systems.
Pulmonary fibrosis is a deadly disease in which the lungs become thickened and scarred, gradually losing their ability to deliver oxygen to the body. Now, scientists at UC San Francisco have ...
Department of Chemical and Biological Engineering, Iowa State University, Ames, Iowa 50011, United States Nanovaccine Institute, Iowa State University, Ames, Iowa 50012, United States ...
Has someone ever surprised you? I don’t mean like a surprise party or a jump scare but like a situation where they tell you something, and when you find out what they really mean, it’s quite a bit ...
MIT and Harvard scientists have created engineered CAR-NK cells that can hide from the immune system and more effectively destroy cancer. The cells are designed to suppress immune-rejection signals ...
Qualcomm's acquisition gives it access to millions of developers in the Arduino ecosystem while also supporting its platform strategy for embedded devices, which now extends across hardware, software, ...
Source: Getty Images This fact sheet explains how squamous cell carcinoma (SCC) is staged and describes each stage. The stage of squamous cell carcinoma depends on how large the tumor is, how deeply ...
Qualcomm (NASDAQ:QCOM) disclosed on Tuesday that it is acquiring hardware startup Arduino to expand the San Diego-based chipmaker's presence in the automation and robotics markets. Terms of the deal ...
SAN FRANCISCO, Oct 7 (Reuters) - Qualcomm (QCOM.O), opens new tab on Tuesday said it has acquired Arduino, an Italian not-for-profit firm that makes hardware and software for developing prototypes of ...
Smartphone processor and modem maker Qualcomm is acquiring Arduino, the Italian company known mainly for its open source ecosystem of microcontrollers and the software that makes them function. In its ...
The class of immune cells at the centre of Monday’s Nobel prize is showing promise as a treatment for autoimmune diseases, cancer and even organ transplants — but there are still key challenges to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback